JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online April 16, 2009, 10.2967/jnumed.108.055533
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liberatore, M.
Right arrow Articles by Rubello, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liberatore, M.
Right arrow Articles by Rubello, D.

Microbial Targeting of 99mTc-Labeled Recombinant Human β-Defensin-3 in an Animal Model of Infection: A Feasibility Pilot Study

Mauro Liberatore1, Alessandro Pala2, Sergio Scaccianoce3, Christos Anagnostou1, Ugo Di Tondo4, Enrico Calandri1, Piera D'Elia2, Milton D. Gross5 and Domenico Rubello6

1 Nuclear Medicine Unit, Department of Radiological Sciences, "La Sapienza" Rome University, Rome, Italy; 2 Perinatology and Puericulture Unit, Laboratory of Biochemistry of Sex Hormones, Department of Gynaecological Sciences, "La Sapienza" Rome University, Rome, Italy; 3 Department of Human Physiology and Pharmacology, "La Sapienza" Rome University, Rome, Italy; 4 Department of Experimental Medicine and Pathology, "La Sapienza" Rome University, Rome, Italy; 5 Nuclear Medicine Service, Department of Veteran Affairs Health System, Ann Arbor, Michigan; and 6 Department of Nuclear Medicine, "S. Maria della Misericordia" Hospital, Rovigo, Italy


Figure 1
View larger version (80K):
[in this window]
[in a new window]

 
FIGURE 1.  Sites of tissue sampling and relative histologic findings (hematoxylin–eosin staining): normal muscle (A), S. aureus–induced infection (B), and carrageenan-induced inflammation (C). Extensive infiltration of leukocytes can be seen in B and C, whereas presence of bacteria was demonstrated in infection site only (B) by cultural examination and Gram staining of relative sample.

 

Figure 2
View larger version (15K):
[in this window]
[in a new window]

 
FIGURE 2.  Dose-dependent uptake of 99mTc-labeled HBD-3 by infection (A) and sterile inflammation (B) sites. Normal muscle (C) was used as control. Nor. = normal.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.